Marina Warner mainly investigates Microbiology, Klebsiella pneumoniae, Enterobacteriaceae, Colistin and Antibacterial agent. Her Microbiology research is multidisciplinary, incorporating elements of Ceftazidime and Escherichia coli, Enterobacter. Marina Warner has included themes like Klebsiella, Beta-lactamase, Imipenem and Meropenem in her Klebsiella pneumoniae study.
The various areas that Marina Warner examines in her Enterobacteriaceae study include Pseudomonas aeruginosa and Antibiotics. In her study, Acinetobacter, Acinetobacter baumannii, Amikacin and Carbapenem is strongly linked to Tigecycline, which falls under the umbrella field of Colistin. Her Antibacterial agent research includes elements of Ribosomal RNA, Biotechnology, Sequence analysis and Linezolid.
Her primary scientific interests are in Microbiology, Antibacterial agent, Enterobacteriaceae, Cephalosporin and Antibiotics. Her Microbiology research is multidisciplinary, relying on both Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus. Marina Warner has researched Antibacterial agent in several fields, including Enterococcus faecium, Penicillin, Enterococcus faecalis, Antibiotic resistance and Linezolid.
Her Enterobacteriaceae research incorporates themes from Pseudomonas aeruginosa and Enterobacter. Her Cephalosporin study also includes
Microbiology, Enterobacteriaceae, Antibacterial agent, Cephalosporin and Agar dilution are her primary areas of study. Her studies in Microbiology integrate themes in fields like Pseudomonas aeruginosa and Methicillin-resistant Staphylococcus aureus, Staphylococcus aureus. Her research in Enterobacteriaceae intersects with topics in Ceftazidime, Cefepime, Aztreonam and Meropenem.
Her research integrates issues of Tigecycline and Antibiotic resistance in her study of Antibacterial agent. Her studies deal with areas such as Klebsiella, Stenotrophomonas maltophilia and Etest as well as Agar dilution. The study incorporates disciplines such as New Delhi metallo-beta-lactamase 1 and Colistin in addition to Biotechnology.
Her primary areas of study are Microbiology, Enterobacteriaceae, Antibiotics, Pseudomonas aeruginosa and Klebsiella pneumoniae. Marina Warner works in the field of Microbiology, focusing on Drug resistance in particular. Her work deals with themes such as Ceftazidime, Stenotrophomonas maltophilia, Imipenem and Cephalosporin, which intersect with Enterobacteriaceae.
Marina Warner specializes in Antibiotics, namely Antibacterial agent. The Antibacterial agent study combines topics in areas such as Cloxacillin and Meropenem. Her work carried out in the field of New Delhi metallo-beta-lactamase 1 brings together such families of science as Molecular epidemiology and Antibiotic resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy;Mark Alexander Howard Toleman;Timothy Rutland Walsh;Jay Bagaria.
Lancet Infectious Diseases (2010)
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK
N. Woodford;M. E. Ward;M. E. Kaufmann;J. Turton.
Journal of Antimicrobial Chemotherapy (2004)
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
David M. Livermore;Marina Warner;Shazad Mushtaq;Michel Doumith.
International Journal of Antimicrobial Agents (2011)
Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)
Alan P. Johnson;Hazel M. Aucken;Susan Cavendish;Mark Ganner.
Journal of Antimicrobial Chemotherapy (2001)
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
D. M. Livermore;S. Mushtaq;M. Warner;J.-C. Zhang.
Journal of Antimicrobial Chemotherapy (2011)
Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae
David M. Livermore;Shazad Mushtaq;Marina Warner;Jiancheng Zhang.
Antimicrobial Agents and Chemotherapy (2011)
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)
Caroline J. Henwood;Tess Gatward;Marina Warner;Dorothy James.
Journal of Antimicrobial Chemotherapy (2002)
A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin
C.G. Giske;C.G. Giske;L. Gezelius;Ø. Samuelsen;M. Warner.
Clinical Microbiology and Infection (2011)
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
David M Livermore;Marina Warner;Shazad Mushtaq.
Journal of Antimicrobial Chemotherapy (2013)
Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England
Juliana M. Coelho;Jane F. Turton;Mary E. Kaufmann;Judith Glover.
Journal of Clinical Microbiology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: